EUCTR2009-014816-37-IT进行中（未招募）不适用
Open prospective, uncontrolled pilot study to assess the tolerability and efficacy of Lymdiaral injektopas (Pascoe-Named) in the treatment of pannicolopatia-edema-fibrosclerotic (PEFS) and venous-lymphatic insufficiency chronic (IVLC)through technical intradermotherapy District (ITD) - tolerability and efficacy of Lymdiaral injektopas
AMED SR0 个研究点开始时间: 2009年11月5日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •-Age> 18 years -Suffering from IVLC connected to PEFS
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Will be excluded from the study subjects who also have one of the following signs or symptoms or conditions: - Secondary Edema to other diseases (disendocrinopatie, kidney disease, liver disease, connective, heart disease). - Patients suffering from incontinence of hemodynamic precludes saphenous-femoral - Pharmacological treatments in progress that may change the evaluation of results (corticosteroids, estrogen-progestine, Ca-antagonists phlebotonic, diuretics). - History pathological autoimmune disorders, neoplastic and paraneoplastic syndromes. - History pathological positive for allergy to medications in general. - Hypersensitivity to one or more components of the product concerned and the composite. -Pharmacological treatments in progress that may change the evaluation of results (corticosteroids, estrogen-progestine, Ca-antagonists, phlebotonic, diuretics) - In Combination with other methods for the same pathology. - Pregnancy - Breastfeeding - In diet therapy treatment - Participation in other clinical studies during the previous six months - Conditions that in the opinion of the physician evaluator, interfere with the ongoing study
研究者
相似试验
已完成
2 期
An uncontrolled, open label pilot-study assessing the efficacy in reducing bleeding severity, and the safety of oral tacrolimus in patients with hereditary hemorrhagic telangiectasiaNL-OMON48255Sint Antonius Ziekenhuis20
进行中（未招募）
1 期
Tacrolimus for bleeding in hereditary hemorrhagic telangiectasia patientsEUCTR2019-003585-40-NLSt. Antonius Hospital20
尚未招募
不适用
A prospective study to assess the effect of adalimumab on cardiovascular biomarkers in participants with severe chronic plaque psoriasisChronic plaque psoriasisSkin - Dermatological conditionsInflammatory and Immune System - Other inflammatory or immune system disordersACTRN12613000419763Dr Anna Braue15
进行中（未招募）
不适用
An open label, randomized pilot study to evaluate diagnostic treatment interruption in HIV-positive children under a stable antiretroviral therapy in order to save medication and reduce possible side effects.B24Unspecified human immunodeficiency virus [HIV] diseaseDRKS00000473J.W. Goethe UniversitätZentrum für Kinder- und Jugendmedizin1
招募中
2 期
Study to evaluate the efficacy of Sucralfate as a healing agent in bed sores.CTRI/2016/03/006745Internal FLUID Grant Christian Medical College Vellore30